» Articles » PMID: 37086524

Enhanced Recovery After Surgery (ERAS®) Society Guidelines for Gynecologic Oncology: Addressing Implementation Challenges - 2023 Update

Overview
Journal Gynecol Oncol
Date 2023 Apr 22
PMID 37086524
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite evidence supporting its use, many Enhanced Recovery After Surgery (ERAS) recommendations remain poorly adhered to and barriers to ERAS implementation persist. In this second updated ERAS® Society guideline, a consensus for optimal perioperative care in gynecologic oncology surgery is presented, with a specific emphasis on implementation challenges.

Methods: Based on the gaps identified by clinician stakeholder groups, nine implementation challenge topics were prioritized for review. A database search of publications using Embase and PubMed was performed (2018-2023). Studies on each topic were selected with emphasis on meta-analyses, randomized controlled trials, and large prospective cohort studies. These studies were then reviewed and graded by an international panel according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system.

Results: All recommendations on ERAS implementation challenge topics are based on best available evidence. The level of evidence for each item is presented accordingly.

Conclusions: The updated evidence base and recommendations for stakeholder derived ERAS implementation challenges in gynecologic oncology are presented by the ERAS® Society in this consensus review.

Citing Articles

Evaluating the role of nursing interventions in enhanced recovery after surgery for minimally invasive spine surgery: a retrospective analysis.

Zhang D, Ding H, Shen C, Liu Y, Jia N Front Surg. 2025; 12:1519135.

PMID: 40046500 PMC: 11880021. DOI: 10.3389/fsurg.2025.1519135.


Effect of Whey Protein Supplementation on Postoperative Outcomes After Gynecological Cancer Surgery: A Randomized Controlled Trial.

Chitti W, Insin P, Prueksaritanond N World J Oncol. 2025; 16(1):70-82.

PMID: 39850521 PMC: 11750756. DOI: 10.14740/wjon1990.


The use of direct oral anticoagulants (DOACs) for thromboprophylaxis during neoadjuvant chemotherapy and after interval debulking surgery in ovarian cancer patients - Maximizing prevention of venous thromboembolism (VTE).

Straughn Jr J, Boitano T Gynecol Oncol Rep. 2025; 56():101551.

PMID: 39777303 PMC: 11705380. DOI: 10.1016/j.gore.2024.101551.


Return to intended oncological therapy following advanced ovarian cancer surgery: a narrative review.

Tse K, Chu M, Chiu J, Kwok S, Irwin M, Chan A Anaesthesia. 2025; 80 Suppl 2():106-114.

PMID: 39776385 PMC: 11744417. DOI: 10.1111/anae.16521.


Implementation of enhanced recovery protocols in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for metastatic ovarian cancer following neoadjuvant chemotherapy. A feasibility study.

Pandraklakis A, Liakou C, La Russa M, Ochoa-Ferraro R, Stearns A, Burbos N Gynecol Oncol Rep. 2024; 56:101536.

PMID: 39524471 PMC: 11550337. DOI: 10.1016/j.gore.2024.101536.